Gold nanoparticles useful in treating lung cancer finds study

08 Aug 2017

1

A recent study has shown that gold could boost the effectiveness of drugs used to treat lung cancer cells. The Independent reported that the precious metal increased the effectiveness of drugs used to treat lung cancer cells.

The research team encased minute fragments called gold nanoparticles, in a chemical device.

While this has not yet been tested on humans, it is hoped that a device of the kind could one day be used to reduce side effects of current chemotherapy treatments by precisely targeting diseased cells without damaging healthy tissue.

Gold is a safe chemical element and can accelerate, or catalyse, chemical reactions. The scientists discovered properties of the metal that allowed these catalytic abilities to be accessed in living things without any side effects.

The device has been shown to be effective after its implantation in the brain of a zebrafish, suggesting it can be used in living animals. The study was carried out in collaboration with researchers at the University of Zaragoza's Institute of Nanoscience of Aragon in Spain, which was funded by Cancer Research UK (CRUK), and the Engineering and Physical Sciences Research Council.

Dr Asier Unciti-Broceta, from the University of Edinburgh's CRUK Edinburgh Centre, said, "We have discovered new properties of gold that were previously unknown and our findings suggest that the metal could be used to release drugs inside tumours very safely.''

A package could be developed to target only the diseased and cancerous cells and leaving the healthy cells alone, drastically cutting the harmful and potentially life threatening side effects of chemotherapy as we know it today.

According to Dr Unciti-Broceta, gold was not known to have this property of a delivery metal that could carry the chemotherapy drugs directly into the tumour and thus prevent it from affecting the healthy cells in its path of travel. But he called it a ''step forward''.

This could lead to a technology in future where a device could be made that could go directly into the tumour with the doctor being able to control the release of the drug into the tumour alone, according to experts.

Latest articles

Anthropic’s revenue run-rate doubles in India in four months as Claude adoption surges

Anthropic’s revenue run-rate doubles in India in four months as Claude adoption surges

Alibaba launches Qwen3.5 as competition heats up in the 'agentic AI' race

Alibaba launches Qwen3.5 as competition heats up in the 'agentic AI' race

Big Tech loses billions as AI spending concerns weigh on valuations

Big Tech loses billions as AI spending concerns weigh on valuations

The analog antidote: why Americans are trading algorithms for physical media

The analog antidote: why Americans are trading algorithms for physical media

UK weighs faster defence spending hike toward 3% as security pressures mount

UK weighs faster defence spending hike toward 3% as security pressures mount

China opens market to 53 African nations in zero-tariff pivot

China opens market to 53 African nations in zero-tariff pivot

Modi’s rooftop solar push slows as lenders and states drag feet

Modi’s rooftop solar push slows as lenders and states drag feet

India hosts global AI summit as tech leaders gather in Delhi amid investment push

India hosts global AI summit as tech leaders gather in Delhi amid investment push

OpenClaw founder Peter Steinberger joins OpenAI as personal-agent project moves to foundation

OpenClaw founder Peter Steinberger joins OpenAI as personal-agent project moves to foundation